Skip to main content
Journal cover image

Corrections needed to 2016 ESC and AHA guidelines on heart failure.

Publication ,  Journal Article
Rydén, L; Van de Werf, F; Armstrong, PW; McGuire, DK; Standl, E; Peterson, ED; Holman, RR
Published in: Lancet Diabetes Endocrinol
May 2017

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Lancet Diabetes Endocrinol

DOI

EISSN

2213-8595

Publication Date

May 2017

Volume

5

Issue

5

Start / End Page

325 / 326

Location

England

Related Subject Headings

  • Incretins
  • Hypoglycemic Agents
  • Humans
  • Heart Failure
  • Guidelines as Topic
  • Dipeptidyl-Peptidase IV Inhibitors
  • 3205 Medical biochemistry and metabolomics
  • 3202 Clinical sciences
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Rydén, L., Van de Werf, F., Armstrong, P. W., McGuire, D. K., Standl, E., Peterson, E. D., & Holman, R. R. (2017). Corrections needed to 2016 ESC and AHA guidelines on heart failure. Lancet Diabetes Endocrinol, 5(5), 325–326. https://doi.org/10.1016/S2213-8587(17)30102-X
Rydén, Lars, Frans Van de Werf, Paul W. Armstrong, Darren K. McGuire, Eberhard Standl, Eric D. Peterson, and Rury R. Holman. “Corrections needed to 2016 ESC and AHA guidelines on heart failure.Lancet Diabetes Endocrinol 5, no. 5 (May 2017): 325–26. https://doi.org/10.1016/S2213-8587(17)30102-X.
Rydén L, Van de Werf F, Armstrong PW, McGuire DK, Standl E, Peterson ED, et al. Corrections needed to 2016 ESC and AHA guidelines on heart failure. Lancet Diabetes Endocrinol. 2017 May;5(5):325–6.
Rydén, Lars, et al. “Corrections needed to 2016 ESC and AHA guidelines on heart failure.Lancet Diabetes Endocrinol, vol. 5, no. 5, May 2017, pp. 325–26. Pubmed, doi:10.1016/S2213-8587(17)30102-X.
Rydén L, Van de Werf F, Armstrong PW, McGuire DK, Standl E, Peterson ED, Holman RR. Corrections needed to 2016 ESC and AHA guidelines on heart failure. Lancet Diabetes Endocrinol. 2017 May;5(5):325–326.
Journal cover image

Published In

Lancet Diabetes Endocrinol

DOI

EISSN

2213-8595

Publication Date

May 2017

Volume

5

Issue

5

Start / End Page

325 / 326

Location

England

Related Subject Headings

  • Incretins
  • Hypoglycemic Agents
  • Humans
  • Heart Failure
  • Guidelines as Topic
  • Dipeptidyl-Peptidase IV Inhibitors
  • 3205 Medical biochemistry and metabolomics
  • 3202 Clinical sciences
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences